Dr. Meador brings to Wax-it Histology Services Inc. his wealth of experience in drug development for diverse therapeutic areas of all molecule type, his in-depth understanding of GLP regulation, and more. He has 25 years of experience working in top tier global pharmaceutical and contract research organization companies, and has held a number of prominent positions over the years, including Director, Toxicology and Pathology for Eli Lilly; Executive Director, Toxicology for Amgen; and VP and Global Head, Pathology for Covance. Since April 2016, Dr. Meador has become the business owner of Pacific Tox Path, LLC, a Pacific Northwest-based Consultation and Contract company for preclinical drug development. Dr. Meador received his D.V.M in 1981 and his Ph.D. in Veterinary Pathology in 1988 from Iowa State University. He is dual certified as a diplomate of American College of Veterinary Pathology in 1989 (anatomic) and 1991 (clinical).